Orthokine

Orthogen is a German biotechnology company specializing in molecular orthopedics and regenerative medicine. The company is best known for developing Orthokine, an autologous conditioned serum (ACS) therapy used to treat osteoarthritis and spinal disorders. The technology involves processing a patient's own blood to concentrate anti-inflammatory proteins, specifically interleukin-1 receptor antagonists (IL-1Ra), which are then re-injected into the affected area. Orthogen's approach focuses on biological treatments that modulate the body's inflammatory response to promote healing and reduce pain without synthetic drugs. The therapy has gained international recognition and is utilized by professional athletes and clinics worldwide. Orthogen continues to research molecular signaling pathways to expand the applications of its autologous protein technologies.